Su1943: CORRELATION OF BIOCHEMICAL, ENDOSCOPIC AND HISTOLOGIC ENDPOINTS IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS: A POST-HOC ANALYSIS FROM THE VIEWS RANDOMISED CONTROLLED TRIAL
Aviv Pudipeddi(The University of Sydney), Rupert W. Leong(The University of Sydney), Craig Haifer(University of Sydney), Ramesh Paramsothy(Liverpool Hospital), Peter De Cruz(The University of Melbourne), Mark Ward, Jakob Begun, Susan J. Connor(Liverpool Hospital), Pak Wo Chan, Melissa Kermeen(Concord Repatriation General Hospital), Viraj C. Kariyawasam(Concord Repatriation General Hospital), Diane Redmond(Concord Repatriation General Hospital), Simon Ghaly(UNSW Sydney), Yoon‐Kyo An(Mater Hospital), Crispin Corte(Royal Prince Alfred Hospital), Sudarshan Paramsothy(University of Chicago), Caroline L. Fung(Concord Repatriation General Hospital), Fadi H. Mourad(Concord Repatriation General Hospital)
Cited by 0
Related Papers
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
|Journal of Crohn s and Colitis|2017|425
Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study
|Journal of Crohn s and Colitis|2013|114
Defined microbiota transplant restores Th17/RORγt <sup>+</sup> regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas
|Proceedings of the National Academy of Sciences|2020|107
Ulcerative Colitis and Cytomegalovirus Infection: From A to Z
|Journal of Crohn s and Colitis|2020|102